DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3zp65x/preventive_asthma) has announced the addition of the "Preventive Asthma Drug Market Outlook 2020" report to their offering.
Asthma is showing high prevalence worldwide. About 300 Million people are suffering from asthma. This is due to continuously deteriorating air quality, which is causing several allergies. In recent years, researchers have explored wide variety of preventive drugs that can delay asthma attacks. These drugs are being highly acknowledged by the doctors and consumers.
The practice of prescribing preventive drugs by doctors is gaining momentum in the US, Europe and Asia-Pacific. Foreseeing the demand, several pharma players are shifting their R&D focus towards preventive asthma drugs. Some of the leading players in the pharma industry include Glaxosmithkline, Astrazeneca, Merck, Novartis, Roche, and others. The drugs by these players contributed millions of dollars to their revenue in 2014.
The report covers key drivers & challenges, and trends & developments that are peculiar to the drug market. The research includes estimated market figures of 2014, and forecasted numbers till 2020. The market was estimated at $22 Billion in 2014.
Researchers are combining corticosteroids with other form of drugs, such as long acting beta agonists in a single inhaler. The so called combination therapy is providing several benefits over the single dose. However, the market is facing few challenges like side-effects posed by such drugs, their high cost and lack of awareness in India, China, and other Middle East & Asia-Pacific countries.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Asthma - An Introduction
4. Drivers & Challenges
5. Preventive Asthma Drugs Market Overview
6. Market Segmentation
7. Trends & Developments
8. Competitive Assessment
For more information visit http://www.researchandmarkets.com/research/3zp65x/preventive_asthma
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716